Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The complicated use of dupilumab in the treatment of atypical generalized pemphigus Erythematous: A report of two cases. | Hum Vaccin Immunother | 2023 | 36798973 | PubTator, text mining | PubMed |
| A study of differential microRNA expression profile in migraine: the microMIG exploratory study. | J Headache Pain | 2023 | 36797674 | PubTator, text mining | PubMed |
| Melanoma molecular subtyping and scoring model construction based on ligand-receptor pairs. | Front Genet | 2023 | 36777724 | PubTator, text mining | PubMed |
| Successful Management of Severe Recalcitrant Pemphigus Vulgaris with Lenalidomide. | Indian Dermatol Online J | 2023 | 36776174 | PubTator, text mining | PubMed |
| Epidermolysis Bullosa Acquisita-Current and Emerging Treatments. | J Clin Med | 2023 | 36769788 | PubTator, text mining | PubMed |
| Self-reactive IgE and anti-IgE therapy in autoimmune diseases. | Front Pharmacol | 2023 | 36755957 | PubTator, text mining | PubMed |
| Two asymptomatic facial erythematous macules in an adult male. | Skin Health Dis | 2023 | 36751324 | PubTator, text mining | PubMed |
| Proteomic profiling of sweat in patients with cystic fibrosis provides new insights into epidermal homoeostasis. | Skin Health Dis | 2023 | 36751320 | PubTator, text mining | PubMed |
| COVID-19 and autoimmune bullous diseases: Lessons learned. | Autoimmun Rev | 2023 | 36738951 | PubTator, text mining | PubMed |
| The therapeutic age of the neonatal Fc receptor. | Nat Rev Immunol | 2023 | 36726033 | PubTator, text mining | PubMed |
| Epithelial Barrier in the Nasal Mucosa, Related Risk Factors and Diseases. | Int Arch Allergy Immunol | 2023 | 36724763 | PubTator, text mining | PubMed |
| Engineering edgeless human skin with enhanced biomechanical properties. | Sci Adv | 2023 | 36706190 | PubTator, text mining | PubMed |
| Research on the pathological mechanism of rectal adenocarcinoma based on DNA methylation. | Medicine (Baltimore) | 2023 | 36705386 | PubTator, text mining | PubMed |
| Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry. | PLoS Pathog | 2023 | 36701392 | PubTator, text mining | PubMed |
| Deregulated phenotype of autoreactive Th17 and Treg clone cells in pemphigus vulgaris after in-vitro treatment with desmoglein antigen (Dsg-3). | Immunobiology | 2023 | 36689824 | PubTator, text mining | PubMed |
| The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. | Curr Oncol | 2023 | 36661697 | PubTator, text mining | PubMed |
| Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. | Nat Biotechnol | 2023 | 36658341 | PubTator, text mining | PubMed |
| Preface to The Journal of Dermatology special issue: What's new in autoimmune bullous diseases. | J Dermatol | 2023 | 36651269 | PubTator, text mining | PubMed |
| The human skin organ culture model as an optimal complementary tool for murine pemphigus models. | Lab Anim | 2023 | 36647613 | PubTator, text mining | PubMed |
| Lifestyle medicine approach in managing pemphigus vulgaris: A case report. | Explore (NY) | 2023 | 36646613 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers?page=19